BGICC 2022 - 14th breast- Gynecological & Immunooncology International Cancer Conference
Jan 20 - Jan 21, 2022 | CairoEgypt
LARVOL is not affiliated with 14th breast- Gynecological & Immunooncology International Cancer Conference and all trademarks, logos, and brand names are property of their respective owners
Condition
Product
MOA
Trial Name/ID
Showing 2 abstracts linked to Trials
Randomized prospective study of accelerated hypofractionated whole breast irradiation plus con-comitant boost versus sequential boost following breast conservative surgery: 2-year outcomes.
RANDOMIZED TRIAL COMPARING 3 SCHEDULES OFHYPOFRACTIONATED WHOLE BREAST IRRADIATIONIN FEMALES WITH EARLY-STAGE BREAST CANCE: THREE- YEARS RESULTS